Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas
Yaniv Kazansky(Memorial Sloan Kettering Cancer Center), Alex Kentsis(Memorial Sloan Kettering Cancer Center)
Cited by 4
Related Papers
Peptidomimetic blockade of MYB in acute myeloid leukemia
|Nature Communications|2018|95
Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms’ tumor
|JCI Insight|2019|29
Peptidomimetic blockade of MYB in acute myeloid leukemia
|bioRxiv (Cold Spring Harbor Laboratory)|2017|11
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia
|bioRxiv (Cold Spring Harbor Laboratory)|2017|8
Forward genetic screen of human transposase genomic rearrangements
|bioRxiv (Cold Spring Harbor Laboratory)|2016|0